References
- Anlar S, Capan Y, Hinca LaA. (1993). Physico-chemical and bioadhesive properties of polyacrylic acid polymers. Pharmazie 48: 285–7
- Bansal K, Rawat MK, Jain A, et al. (2009). Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS Pharm Sci Tech 10:716–23
- Bohm L, Roos WP, Serafin AM. (2003). Inhibition of DNA repair by pentoxifylline and related methylxanthine derivatives. Toxicology 193:153–60
- Bonacucina G, Martelli S, Gf P. (2004). Rheological, mucoadhesive and release properties of carbopol gels in hydrophilic cosolvents. Int J Pharm 282:115–30
- Brånemark R, Brånemark P, Rydevik B, Myers R. (2001). Osseointegration in skeletal reconstruction and rehabilitation: a review. J Rehab Res Dev 38:175–81
- Cochran DL. (1999). A comparison of Endosseous dental Implant Surfaces. J Periodontol 70:1523–39
- Danester Quinones MS, Evone SG. (2008). Formulation and characterization of nystatin gel. PRHSJ 27:61–7
- Das MK, Palei NN. (2011). Sorbitan ester niosomes for topical delivery of rofecoxib. IJEB 49:438–45
- Deasy P, Collins A, Maccarthy D, Russell R. (1989). Use of strips containing tetracycline hydrochloride or metronidazole for the treatment of advanced periodontal disease. J Pharm Pharmacol 4:694–9
- Efentakis M, Pagoni I, Vlachou M, Avgoustakis K. (2007). Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility. Int J Pharm 339:66–75
- El-Dakrouri WA, Ibrahim HK, Ghorab MK, Ghorab MM. (2010). Enhancement of the intranasal delivery of insulin via a novel mucoadhesive carbopol gel. J Pharm Pharmacol 62:866–72
- Garret IR, Gutierrez G, Mundy GR. (2001). Statins and Bone Formation. Curr Pharm Des 7:715–36
- Ghandi R, Robinson J. (1994). Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev 13:43–74
- Gülin A, Sinem YK, Tangül Ş, et al. (2012). Bioadhesive and mechanical properties of triamcinolone acetonide buccal gels. Turk J Pharm Sci 9:1–12
- Islam MT, Rodriguez-Hornedo N, Ciotti S, Ackermann C. (2004). Rheological characterization of topical carbomer gels neutralized to different pH. Pharm Res 21:1192–9
- Ismail FA. (2006). Design and in vitro evaluation of polymeric formulae of simvastatin for local bone induction. Drug Dev Ind Pharm 32:1199–206
- Ismail FA, Napaporn J, Hughes JA, Brazeau GA. (2000). In situ gel formulations for gene delivery: release and myotoxicity studies. Pharm Dev Technol 5:391–7
- Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol 27:48–9
- Kinoshita T, Kobayashi S, Ebara S, et al. (2000). Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice. Bone 27:811–17
- Korsmeyer RW, Gurny R, Doelker E, et al. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35
- Pose-Vilarnovo B, Rodriguez-Tenreiro C, Rosa Dos Santos JF, et al. (2004). Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J Control Release 94:351–63
- Reddy GT, Kumar TM, Veena KM. (2005). Formulation and evaluation of alendronate sodium gel for the treatment of bone resorptive lesions in periodontitis. Drug Deliv 12:217–22
- Saito N, Okada T, Horiuchi H, et al. (2001). Biodegradable poly-D, L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone. J Bone Joint Surg Am 83:S92–8
- Sareen R, Kumar S, Gupta G. (2011). Meloxicam carbopol-based gels: characterization and evaluation. Curr Drug Deliv 8:407–15
- Shankar NB, Kumar NU, Balakrishna PK. (2009). Bioadhesive vaginal gel for prolong release of metronidazole: formulation development, characterization and comparative study with marketed formulation. Int J Pharm Sci Tech 2:30–6
- Shin SC, Kim HJ, Oh IJ, et al. (2005). Development of tretinoin gels for enhanced transdermal delivery. Eur J Pharm Biopharm 60:67–71
- Shin SC, Kim JY, Oh IJ. (2000). Mucoadhesive and physicochemical characterization of carbopol-poloxamer gels containing triamcinolone acetonide. Drug Dev Ind Pharm 26:307–12
- Songkro S, Rajatasereekul N, Cheewasrirungrueng N. (2009). In vitro studies of mucoadhesiveness and release of nicotinamide oral gels prepared from bioadhesive polymers. World Academy of Sci Eng, Technol 31:113–20
- Sridevi S, Babu RJ, Mittal N, et al. (1995). Development and evaluation of acrylic strips of metronidazole for the therapy of periodontal disease. Pharmazie 50:153–4
- Sudhakar Y, Kuotsu K, Bandyopadhyay AK. (2006). Buccal bioadhesive drug delivery: a promising option for orally less efficient drugs. J Control Release 114:15–40
- Sean C Sweetman (ed). (2011). Martindale: the complete drug reference, 37th ed. London, UK: Pharmaceutical Press
- Tsutsumimoto T, Kawasaki S, Ebara S, Takaoka K. (1999). TNF-alpha and IL-1beta suppress N-Cadherin expression in MC3T3-E1 Cells. J Bone Miner Res 14:1751–60
- Tsutsumimoto T, Wakabayashi S, Kinoshita T, et al. (2002). A phosphodiesterase inhibitor, pentoxifylline, enhances the Bone Morphogenetic Protein-4 (BMP-4)-dependent differentiation of osteoprogenitor cells. Bone 31:396–401
- Tur KM, Ch'ng HS. (1998). Evaluation of possible mechanism(s) of bioadhesion. Int J Pharm 160:61–74
- Varshosaz J, Tavakoli N, Saidian S. (2002). Development and physical characterization of a periodontal bioadhesive gel of metronidazole. Drug Deliv 9:127–33
- Wissing S, Craig DQ, Barker SA, Moore WD. (2000). An investigation into the use of stepwise isothermal high sensitivity DSC as a means of detecting drug-excipient incompatibility. Int J Pharm 199:141–50